SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-006225
Filing Date
2019-05-01
Accepted
2019-05-01 08:16:28
Documents
75
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 511627
2 ex31-1.htm EX-31.1 18827
3 ex31-2.htm EX-31.2 18889
4 ex32-1.htm EX-32.1 6412
5 ex32-2.htm EX-32.2 6543
  Complete submission text file 0001493152-19-006225.txt   3160497

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE vbiv-20190331.xml EX-101.INS 459824
7 XBRL SCHEMA FILE vbiv-20190331.xsd EX-101.SCH 64111
8 XBRL CALCULATION FILE vbiv-20190331_cal.xml EX-101.CAL 65973
9 XBRL DEFINITION FILE vbiv-20190331_def.xml EX-101.DEF 146685
10 XBRL LABEL FILE vbiv-20190331_lab.xml EX-101.LAB 344132
11 XBRL PRESENTATION FILE vbiv-20190331_pre.xml EX-101.PRE 238734
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37769 | Film No.: 19784886
SIC: 2834 Pharmaceutical Preparations